公开(公告)号：US08174325B1

公开(公告)日：2012-05-08

申请号：US12903287

申请日：2010-10-13

申请人： Daniel Leung ,  Joseph Neff ,  Norman Liu ,  Visarath In

发明人： Daniel Leung ,  Joseph Neff ,  Norman Liu ,  Visarath In

IPC分类号： H03B27/00

CPC分类号： H03L7/24

摘要： The present invention provides an array of tunable, injection-locking oscillators which are scalable to higher frequencies and measure the entire relevant frequency space simultaneously. The scalable, highly-parallelized, adaptive receiver architecture uses arrays of tunable, injection-locking nonlinear oscillator rings for broad spectrum RF analysis. Three separate and different microelectronic circuit configurations, each having a different type of readout, are described. The embodiments are designed to be incorporated as a subsystem in any type of powered system in which a fast image of the broader spectrum is valuable, when no information about the location of signals in the frequency space is predictable or forthcoming.

摘要翻译： 本发明提供了一种可调谐的注入锁定振荡器阵列，其可扩展到更高频率并同时测量整个相关频率空间。 可扩展，高度并行化的自适应接收机架构使用可调谐注入锁定非线性振荡器环的阵列进行广谱RF分析。 描述了具有不同类型的读出的三个独立且不同的微电子电路配置。 这些实施例被设计为并入作为任何类型的动力系统中的子系统，其中当频率空间中的信号的位置的信息是可预测的或即将到来时，其中较广谱的快速图像是有价值的。

公开(公告)号：US06291447B1

公开(公告)日：2001-09-18

申请号：US09258991

申请日：1999-02-26

申请人： Raymond Andersen ,  Michel Roberge ,  Jasbinder Sanghera ,  Daniel Leung ,  Edward Piers ,  Roberto GS Berlinck ,  Robert Britton

发明人： Raymond Andersen ,  Michel Roberge ,  Jasbinder Sanghera ,  Daniel Leung ,  Edward Piers ,  Roberto GS Berlinck ,  Robert Britton

IPC分类号： C07D48714

CPC分类号： C07D487/14 ,  C07H9/06 ,  C07H19/044 ,  C07H19/23

摘要： Novel granulatimide compounds and pharmaceutical formulations thereof are provided. Compounds of this invention have the general formula: wherein are independently R or Z as defined below, or in combination F and F′ is Ar1 as defined below; Ar1 is a monocyclic, bicyclic or tricyclic, fully or partially aromatic system containing five or six membered carbocyclic or, oxygen, nitrogen or sulphur containing heterocyclic rings, optionally substituted with R or Z; W is selected from the group consisting of formula (i); (ii) or (iii), wherein the structures are as follows:

摘要翻译： 提供了新的颗粒酰亚胺化合物及其药物制剂。 本发明的化合物具有以下通式：其中独立地为如下定义的R或Z，或者组合F和F'如下定义的Ar 1; Ar 1是单环，双环或三环，全部或部分芳族体系，其含有五或六个 任选被R或Z取代的W，W选自由式（ⅰ）组成的组; （ii）或（iii），其中结构如下：